These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34546862)

  • 1. The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19.
    Kasugai D; Jingushi N; Omote N; Shindo Y; Goto Y
    Am J Respir Crit Care Med; 2021 Dec; 204(12):1489. PubMed ID: 34546862
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Kasugai
    Rouzé A; Labreuche J; Nseir S
    Am J Respir Crit Care Med; 2021 Dec; 204(12):1489-1491. PubMed ID: 34546857
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 pneumonia and the appropriate use of antibiotics.
    Ginsburg AS; Klugman KP
    Lancet Glob Health; 2020 Dec; 8(12):e1453-e1454. PubMed ID: 33188730
    [No Abstract]   [Full Text] [Related]  

  • 4. Appropriate use of antimicrobial therapy for COVID-19 co-infection.
    Lai CC; Yu WL
    Immunotherapy; 2021 Sep; 13(13):1067-1070. PubMed ID: 34114473
    [No Abstract]   [Full Text] [Related]  

  • 5. Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.
    Chang CY; Chan KG
    J Infect; 2020 Sep; 81(3):e29-e30. PubMed ID: 32628960
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
    Furukawa D; Graber CJ
    Clin Infect Dis; 2021 May; 72(10):e542-e544. PubMed ID: 32857832
    [No Abstract]   [Full Text] [Related]  

  • 7. Could the COVID-19 pandemic aggravate antimicrobial resistance?
    Rossato L; Negrão FJ; Simionatto S
    Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of Bacterial Coinfection in COVID-19 Patients Is a Missing Piece of the Puzzle in the COVID-19 Management in Indonesia.
    Prasetyoputri A
    ACS Infect Dis; 2021 Feb; 7(2):203-205. PubMed ID: 33502840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfections with Other Respiratory Pathogens among Patients with COVID-19.
    Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R
    Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19.
    Ripa M; Mastrangelo A
    Chest; 2021 Aug; 160(2):387-388. PubMed ID: 34366018
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
    Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19.
    Stevenson DR; Sahemey M; Cevallos Morales J; Martín-Lázaro J; Buchanan R; Serafino Wani R
    Clin Infect Dis; 2021 Jun; 72(11):e926. PubMed ID: 33038229
    [No Abstract]   [Full Text] [Related]  

  • 13. The microbial coinfection in COVID-19.
    Chen X; Liao B; Cheng L; Peng X; Xu X; Li Y; Hu T; Li J; Zhou X; Ren B
    Appl Microbiol Biotechnol; 2020 Sep; 104(18):7777-7785. PubMed ID: 32780290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Coinfections in COVID-19 Patients without a Positive Microbiologic Result: a Word of Caution.
    Casalini G; Pozza G; Giacomelli A; Antinori S
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0229621. PubMed ID: 34978885
    [No Abstract]   [Full Text] [Related]  

  • 15. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
    Buetti N; Mazzuchelli T; Lo Priore E; Balmelli C; Llamas M; Pallanza M; Elzi L; Consonni V; Trimboli P; Forni-Ogna V; Bernasconi E
    J Infect; 2020 Aug; 81(2):e148-e149. PubMed ID: 32512022
    [No Abstract]   [Full Text] [Related]  

  • 17. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.
    Vaughn VM; Gandhi TN; Petty LA; Patel PK; Prescott HC; Malani AN; Ratz D; McLaughlin E; Chopra V; Flanders SA
    Clin Infect Dis; 2021 May; 72(10):e533-e541. PubMed ID: 32820807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considering Futility of Care Decisions in Neurosurgical Practice.
    Olson S; Honeybul S; Rosenfeld JV
    World Neurosurg; 2021 Dec; 156():120-124. PubMed ID: 34563717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infections: testing macrolides for added benefit in patients with COVID-19.
    Sterenczak KA; Barrantes I; Stahnke T; Stachs O; Fuellen G; Undre N
    Lancet Microbe; 2020 Dec; 1(8):e313. PubMed ID: 33521730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.